Myastenic Syndrome Diagnosed After Treatment of Small Cell Lung Cancer with Atezolizumab (PDL-1 Inhibitor)
Bala Başak Öven, İrem Türkmen, Ipek Geyikoğlu, Serkan Çelik, Lidya Aden Çağlar
DOI
Download
Back